Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Garcia-Sanz Ramon; Sureda Anna; Gonzalez Ana Pilar; De la Cruz Fatima; Sanchez-Gonzalez Blanca; Rodriguez Antonia; Domingo-Domenech Eva; Miriam Moreno; Lopez Javier Sr.; Jose Pinana Luis; Rodriguez Gabriela; Canales Miguel; Gutierrez Antonio; Caballero Maria Dolores; Martinez Carmen

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

【24h】

Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

机译：Brentuximab Vedotin加ESHAP（BRESHAP）是一种有效的组合，可在自体干细胞移植之前诱导难治性和复发性霍奇金淋巴瘤患者的缓解：西班牙淋巴瘤和骨髓移植（GELTAMO）试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2016年第22期|共4页
作者
Garcia-Sanz Ramon; Sureda Anna; Gonzalez Ana Pilar; De la Cruz Fatima; Sanchez-Gonzalez Blanca; Rodriguez Antonia; Domingo-Domenech Eva; Miriam Moreno; Lopez Javier Sr.; Jose Pinana Luis; Rodriguez Gabriela; Canales Miguel; Gutierrez Antonio; Caballero Maria Dolores; Martinez Carmen;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO) [J] . Garcia-Sanz Ramon, Sureda Anna, Gonzalez Ana Pilar, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：Brentuximab Vedotin加ESHAP（BRESHAP）是一种有效的组合，可在自体干细胞移植之前诱导难治性和复发性霍奇金淋巴瘤患者的缓解：西班牙淋巴瘤和骨髓移植（GELTAMO）试验
2. Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation [J] . Kaloyannidis Panayotis, Hertzberg Mark, Webb Kate, British Journal of Haematology . 2020,第4期

机译：Brentuximab Vedotin用于治疗自体干细胞移植后复发或难治性霍奇金淋巴瘤的患者
3. Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis [J] . Zinzani Pier Luigi, Chen Robert, Armand Philippe, Leukemia and lymphoma . 2020,第3a4期

机译：Pembrolizumab单药治疗初级耐火经典霍奇金淋巴瘤淋巴瘤，后者复制后复制后爆发性干细胞移植和/或Brentuximab Vedotin治疗：Keynote-087亚组分析
4. Vasoactive Intestinal Polypeptide Induces Regulatory Dendritic Cells Thai Prevent Acute Graft Versus Host Disease and Leukemia Relapse after Bone Marrow Transplantation [C] . MARIO DELGADO, ALEJO CHORNY, DOINA GANEA, International Symposium on VIP, PACAP, and Related Peptides . 2006

机译：血管活性肠道多肽诱导调节性树突细胞泰国预防急性移植物与骨髓移植后宿主病和白血病复发
5. Correlates of fatigue in lymphoma patients undergoing autologous peripheral blood stem cell transplantation. [D] . El-Banna, Majeda Mohammed. 2004

机译：与进行自体外周血干细胞移植的淋巴瘤患者疲劳相关。
6. Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma [O] . A F Herrera, J Palmer, P Martin, -1

机译：二线brentuximab vedotin在复发或难治性霍奇金淋巴瘤中的自体干细胞移植
7. PSY5 Comparing Brentuximab Vedotin Overall Survival Data to Standard of Care in Patients With Relapsed/Refractory Hodgkin Lymphoma (HL) Post-Autologous Stem Cell Transplant (ASCT) [O] . Woods B., Thompson J., Barcena L., 2012

机译：PSY5比较自体干细胞移植（ASCT）后复发/难治性霍奇金淋巴瘤（HL）患者的布伦妥昔单抗维多汀总生存数据与护理标准

Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

著录项

相似文献

相关主题

期刊订阅